期刊
INTERNATIONAL IMMUNOLOGY
卷 29, 期 7, 页码 319-325出版社
OXFORD UNIV PRESS
DOI: 10.1093/intimm/dxx041
关键词
antibody therapy; autoimmunity; cancer; Fc gamma receptor; polymorphism
类别
资金
- JSPS KAKENHI Grant [JP 23500489, JP 25460601, 16K09703]
- Grants-in-Aid for Scientific Research [16K09703] Funding Source: KAKEN
Receptors for the Fc domain of immunoglobulins [Fc receptors (FcRs)] are essential for the maintenance of antibody-mediated immune responses. FcRs consist of activating-and inhibitory-type receptors that regulate adequate thresholds for various immune cells. In particular, polymorphisms and/or gene copy-number variations of FcRs for IgG (Fc gamma Rs) are closely associated with the development of inflammatory disorders, including autoimmune diseases. Recent evidence has implicated polymorphisms of FcRs in the efficacy of monoclonal antibody (mAb)-mediated therapy. This review provides an overview of genetic variations in human Fc gamma Rs and the clinical contribution of Fc gamma R polymorphisms in mAb treatments for cancer, autoimmune diseases and allergies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据